Order Article Reprints

Ihn H-J, Kim Y-S, Lim S, Bae J-S, Jung J-C, Kim Y-H, Park J-W, Wang Z, Koh J-T, Bae Y-C, et al. PF-3845, a Fatty Acid Amide Hydrolase Inhibitor, Directly Suppresses Osteoclastogenesis through ERK and NF-κB Pathways In Vitro and Alveolar Bone Loss In Vivo. International Journal of Molecular Sciences. 2021; 22(4):1915. https://doi.org/10.3390/ijms22041915

Ihn, Hye-Jung, Yi-Seul Kim, Soomin Lim, Jong-Sup Bae, Jae-Chang Jung, Yeo-Hyang Kim, Jin-Woo Park, Zhao Wang, Jeong-Tae Koh, Yong-Chul Bae, and et al. 2021. "PF-3845, a Fatty Acid Amide Hydrolase Inhibitor, Directly Suppresses Osteoclastogenesis through ERK and NF-κB Pathways In Vitro and Alveolar Bone Loss In Vivo" International Journal of Molecular Sciences 22, no. 4: 1915. https://doi.org/10.3390/ijms22041915

Ihn, H.-J., Kim, Y.-S., Lim, S., Bae, J.-S., Jung, J.-C., Kim, Y.-H., Park, J.-W., Wang, Z., Koh, J.-T., Bae, Y.-C., Baek, M.-C., & Park, E.-K. (2021). PF-3845, a Fatty Acid Amide Hydrolase Inhibitor, Directly Suppresses Osteoclastogenesis through ERK and NF-κB Pathways In Vitro and Alveolar Bone Loss In Vivo. International Journal of Molecular Sciences, 22(4), 1915. https://doi.org/10.3390/ijms22041915